×
About 121,123 results

ALLMedicine™ Lung Cancer Center

Research & Reviews  39,539 results

Effects and tolerability of exercise therapy modality on cardiorespiratory fitness in lung cancer: a randomized controlled trial
https://pubmed.ncbi.nlm.nih.gov/34658160/
Journal of Cachexia Sarcopenia and Muscle; Scott JM

Oct 17th, 2021 - Poor cardiorespiratory fitness (CRF) is a cardinal feature of post-treatment primary lung cancer. The most effective exercise therapy regimen to improve CRF has not been determined.

Annual Report to the Nation: Rapid Decrease in Lung Cancer and Melanoma Deaths Lead Overall Continued Decline in Cancer Death Rate
http://pressroom.cancer.org/ARN2021
American Cancer Society

Jul 8th, 2021 - Overall cancer death rates continue to decline in men and women for all racial and ethnic groups in the United States, according to the latest Annual Report to the Nation on the Status of Cancer. During 2001 to 2018, declines in lung cancer death ...

Screening for Lung Cancer
https://www.aafp.org/afp/2021/0700/p79.html
American Family Physician; Tracer H, Pierre J.

Jul 7th, 2021 - S.J., a 68-year-old Black man, comes to your office to establish care after recently moving to the area. S.J. has a history of allergic rhinitis, osteoarthritis, and gastroesophageal reflux disease. Additionally, he has a 39-pack-year history of s...

Real-world treatment patterns and outcomes in small-cell lung cancer: a systematic literature review
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264706/
Journal of Thoracic Disease; Johal S

Jun 13th, 2021 - Small-cell lung cancer (SCLC) accounts for 12–15% of lung cancers and is associated with poor survival outcomes and high symptom burden. This study employed a broad, systematic search strategy and timeframe to identify evidence on real-world treat...

Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung Cancer
https://clinicaltrials.gov/ct2/show/NCT02609776

Dec 3rd, 2021 - This open label (all participants know the identity of the study drug), multicenter (more than one study site), first-in-human study consists of 2 parts. Part 1 is a Amivantamab Monotherapy and Combination Dose Escalations and Part 2 Amivantamab M...

see more →

Guidelines  87 results

Effects and tolerability of exercise therapy modality on cardiorespiratory fitness in lung cancer: a randomized controlled trial
https://pubmed.ncbi.nlm.nih.gov/34658160/
Journal of Cachexia Sarcopenia and Muscle; Scott JM

Oct 17th, 2021 - Poor cardiorespiratory fitness (CRF) is a cardinal feature of post-treatment primary lung cancer. The most effective exercise therapy regimen to improve CRF has not been determined.

Annual Report to the Nation: Rapid Decrease in Lung Cancer and Melanoma Deaths Lead Overall Continued Decline in Cancer Death Rate
http://pressroom.cancer.org/ARN2021
American Cancer Society

Jul 8th, 2021 - Overall cancer death rates continue to decline in men and women for all racial and ethnic groups in the United States, according to the latest Annual Report to the Nation on the Status of Cancer. During 2001 to 2018, declines in lung cancer death ...

Screening for Lung Cancer
https://www.aafp.org/afp/2021/0700/p79.html
American Family Physician; Tracer H, Pierre J.

Jul 7th, 2021 - S.J., a 68-year-old Black man, comes to your office to establish care after recently moving to the area. S.J. has a history of allergic rhinitis, osteoarthritis, and gastroesophageal reflux disease. Additionally, he has a 39-pack-year history of s...

Real-world treatment patterns and outcomes in small-cell lung cancer: a systematic literature review
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264706/
Journal of Thoracic Disease; Johal S

Jun 13th, 2021 - Small-cell lung cancer (SCLC) accounts for 12–15% of lung cancers and is associated with poor survival outcomes and high symptom burden. This study employed a broad, systematic search strategy and timeframe to identify evidence on real-world treat...

Executive Summary: Screening for Lung Cancer: Chest Guideline and Expert Panel Report.
https://doi.org/10.1016/j.chest.2021.07.003
Chest Mazzone PJ, Silvestri GA et. al.

Jul 17th, 2021 - Low-dose chest CT screening for lung cancer has become a standard of care in the United States, in large part because of the results of the National Lung Screening Trial (NLST). Additional evidence supporting the net benefit of low-dose chest CT s...

see more →

Drugs  197 results see all →

Clinicaltrials.gov  2,350 results

Effects and tolerability of exercise therapy modality on cardiorespiratory fitness in lung cancer: a randomized controlled trial
https://pubmed.ncbi.nlm.nih.gov/34658160/
Journal of Cachexia Sarcopenia and Muscle; Scott JM

Oct 17th, 2021 - Poor cardiorespiratory fitness (CRF) is a cardinal feature of post-treatment primary lung cancer. The most effective exercise therapy regimen to improve CRF has not been determined.

Annual Report to the Nation: Rapid Decrease in Lung Cancer and Melanoma Deaths Lead Overall Continued Decline in Cancer Death Rate
http://pressroom.cancer.org/ARN2021
American Cancer Society

Jul 8th, 2021 - Overall cancer death rates continue to decline in men and women for all racial and ethnic groups in the United States, according to the latest Annual Report to the Nation on the Status of Cancer. During 2001 to 2018, declines in lung cancer death ...

Screening for Lung Cancer
https://www.aafp.org/afp/2021/0700/p79.html
American Family Physician; Tracer H, Pierre J.

Jul 7th, 2021 - S.J., a 68-year-old Black man, comes to your office to establish care after recently moving to the area. S.J. has a history of allergic rhinitis, osteoarthritis, and gastroesophageal reflux disease. Additionally, he has a 39-pack-year history of s...

Real-world treatment patterns and outcomes in small-cell lung cancer: a systematic literature review
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264706/
Journal of Thoracic Disease; Johal S

Jun 13th, 2021 - Small-cell lung cancer (SCLC) accounts for 12–15% of lung cancers and is associated with poor survival outcomes and high symptom burden. This study employed a broad, systematic search strategy and timeframe to identify evidence on real-world treat...

A Study to Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell...
https://clinicaltrials.gov/ct2/show/NCT02699606

Dec 3rd, 2021 - This is an open-label (all people know the identity of the intervention), multicenter, phase 2 study to evaluate the clinical efficacy, safety and pharmacokinetics of erdafitinib in Asian participants with advanced NSCLC, urothelial cancer, esopha...

see more →

News  6,225 results

Effects and tolerability of exercise therapy modality on cardiorespiratory fitness in lung cancer: a randomized controlled trial
https://pubmed.ncbi.nlm.nih.gov/34658160/
Journal of Cachexia Sarcopenia and Muscle; Scott JM

Oct 17th, 2021 - Poor cardiorespiratory fitness (CRF) is a cardinal feature of post-treatment primary lung cancer. The most effective exercise therapy regimen to improve CRF has not been determined.

Annual Report to the Nation: Rapid Decrease in Lung Cancer and Melanoma Deaths Lead Overall Continued Decline in Cancer Death Rate
http://pressroom.cancer.org/ARN2021
American Cancer Society

Jul 8th, 2021 - Overall cancer death rates continue to decline in men and women for all racial and ethnic groups in the United States, according to the latest Annual Report to the Nation on the Status of Cancer. During 2001 to 2018, declines in lung cancer death ...

Screening for Lung Cancer
https://www.aafp.org/afp/2021/0700/p79.html
American Family Physician; Tracer H, Pierre J.

Jul 7th, 2021 - S.J., a 68-year-old Black man, comes to your office to establish care after recently moving to the area. S.J. has a history of allergic rhinitis, osteoarthritis, and gastroesophageal reflux disease. Additionally, he has a 39-pack-year history of s...

Real-world treatment patterns and outcomes in small-cell lung cancer: a systematic literature review
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264706/
Journal of Thoracic Disease; Johal S

Jun 13th, 2021 - Small-cell lung cancer (SCLC) accounts for 12–15% of lung cancers and is associated with poor survival outcomes and high symptom burden. This study employed a broad, systematic search strategy and timeframe to identify evidence on real-world treat...

Bevacizumab Add-On No Help in Progressive EGFR-Mutant Lung Cancer
https://www.medpagetoday.com/hematologyoncology/lungcancer/95985

Dec 2nd, 2021 - Adding the angiogenesis inhibitor bevacizumab (Avastin) to osimertinib (Tagrisso) failed to slow progression of advanced EGFR-mutant non-small-cell lung cancer (NSCLC) that had progressed on prior anti-EGFR therapy, a randomized trial showed. Medi...

see more →

Patient Education  51 results see all →